Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Curtis, MA
Alan Robert Douglas Curtis, Acton, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110211708 | SIMULTANEOUS ENHANCEMENT OF TRANSMISSION LOSS AND ABSORPTION COEFFICIENT USING ACTIVATED CAVITIES - A method and apparatus for providing simultaneous enhancement of transmission loss and absorption coefficient using activated cavities is presented. A layer of material is provided, and a backing plate having a plurality of cavities on the top surface of said backing plate, is disposed adjacent a top surface of said layer of material. A screen is disposed along the top surface of said cavities on said backing plate and at least one cavity includes an actuator disposed within the cavity and a control system receiving a signal from the microphone and receiving a signal from the accelerometer and providing a drive signal to the actuator to provide an acoustic output to provide simultaneous insertion loss and absorption which serves to minimize a linear combination of the signal from the microphone and the signal from the accelerometer. | 09-01-2011 |
Dorothy W. Curtis, Framingham, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100127887 | METHOD, APPARATUS AND COMPUTER PROGRAM PRODUCT FOR FACILITATING LOCATION DISCOVERY - A method, apparatus and computer program product are provided to permit location discovery, including location discovery in indoor settings. The method may identify a wireless signature present at a geographical location and determine whether the wireless signature corresponds to a previously observed wireless signature associated with the predefined geographical location. In instances in which the wireless signature fails to correspond to a previously observed wireless signature, the method may also receive an identification of a geographical location and associate, such as by means of a processor, the wireless signature with the identification of the geographical location. A corresponding computer program product and apparatus are also provided. | 05-27-2010 |
| 20110306354 | Method and Apparatus for Constructing a User-Generated Geological System - A method and apparatus are provided to permit location discovery, including location discovery in indoor settings. The method may identify a wireless fingerprint present at a geographical location and determine whether the wireless fingerprint corresponds to a previously observed wireless fingerprint associated with the predefined geographical location. A new wireless fingerprint and a geographical location, or bind, may be received by the system and the system may evaluate whether or not the new bind is erroneous or not, or if the new bind is an improvement over existing binds in determining whether or not to accept the new bind. | 12-15-2011 |
John D. Curtis, Millbury, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090240725 | Persistent Object Linkage Using Ghosting - A system that persistently maintains and exposes one or more previous object hierarchies to which an object belonged across one or more hierarchy destroying operations, such as operations that delete parent objects, add parent objects subsequent to addition of their descendent objects, forward objects to or from the hierarchy, and/or modify hierarchy determining rules. A user interface object allows user access to one or more persistent hierarchies for the corresponding object. A hierarchy list or the like allows a user to select a desired one of the persistent hierarchies. A persistent hierarchy can be accessed in the disclosed system through a display object associated with any object within the hierarchy, including the root, leaves, and any intervening objects. When objects are deleted, “ghost” objects are maintained and displayed to the user in the hierarchical positions of the deleted objects when a persistent hierarchy is displayed. | 09-24-2009 |
John Douglas Curtis, Millbury, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110022573 | PREVENTING TRANSFER AND DUPLICATION OF REDUNDANTLY REFERENCED OBJECTS ACROSS NODES OF AN APPLICATION SYSTEM - Unique identifiers referred to as “keys” are generated for objects stored on each node. When a container object including at least one embedded object is transferred from a sending node to a receiving node, the sending node sends the key uniquely identifying the embedded object to the receiving node to determine whether the embedded object is already stored on the receiving node. If the receiving node indicates that the embedded object is already stored at the receiving node, then the sending node determines that the embedded object does not need to be sent to the receiving node. In that case, if the embedded object has not been sent, the sending node does not send the embedded object. If the sending node has already started sending the embedded object, then the sending node terminates sending of the embedded object. | 01-27-2011 |
Paul Curtis, Sudbury, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090276666 | SYSTEM, METHOD, AND ADAPTER FOR CREATING FAULT-TOLERANT COMMUNICATION BUSSES FROM STANDARD COMPONENTS - A system, method, and adapter for creating fault-tolerant communication busses from standard components, are described. Fault-tolerant interface logic is provided for transmitting and receiving system health and system management signals to and from a module that is designed to be connected to a single RS-485 bus. The fault-tolerant interface logic enables the module to selectively communicate via at least two redundant half-duplex, multipoint, differential RS-485 busses. The fault-tolerant interface logic includes a first RS-485 transceiver connected to a first RS-485 bus, a second RS-485 transceiver connected to a second RS-485 bus, selector logic responsive to a control signal for selecting one of the first and the second busses to receive signals from and for transmitting the received signals to the module, and software logic executable on a baseboard management controller (BMC) chip. The software logic includes control logic for monitoring the health of the selected bus and for providing the control signal to the selector logic. | 11-05-2009 |
Paul M. Curtis, Sudbury, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090290483 | METHOD OF AND A SYSTEM FOR AUTONOMOUSLY IDENTIFYING WHICH NODE IN A TWO-NODE SYSTEM HAS FAILED - A method of and a system for autonomously identifying which node in a two-node system has failed are described. The system includes two nodes and a fault-tolerant communication fabric. The fabric defines a plurality of communication paths connecting the two nodes, and fault-tolerant loop-back communication in which each node can send a message to itself utilizing at least one switch structure of the fabric. In addition, each of the two nodes includes logic for performing the service; logic for testing the functionality of the respective node; logic for sending test result messages to both nodes; fault-isolation logic for analyzing test result messages from both nodes; and logic for disabling the other node from performing the service only if the fault-isolation logic determines that the respective node is capable of successfully performing the service and also determines that the other node is incapable of successfully performing the service. | 11-26-2009 |
Richard R. Curtis, Lynn, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090067395 | Routing Network Requests Based on a Mobile Network Signature - Disclosed are systems and methods for responding to a web page request from a mobile device by providing the network address of a server hosting content formatted for the mobile device. The systems and methods include means and ways for redirecting a request for URL resolution from a DNS server to an enhanced DNS server with facilities to determine the kind of the requesting device, e.g., whether the requesting device is fixed or mobile. | 03-12-2009 |
Rory Curtis, Ashland, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090264410 | THERAPEUTIC COMPOUNDS AND USES THEREOF - Compounds of formula (I) are described herein | 10-22-2009 |
Rory A. Curtis, Ashland, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090306168 | SirT Inhibitors That Bind to NAD - Compound of formula (I) | 12-10-2009 |
Rory A.j. Curtis, Ashland, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090068187 | Novel 14275, 54420, 8797, 27439, 68730, 69112 and 52908 molecules and uses therefor - The invention provides isolated nucleic acids molecules, designated 14275, 54420, 8797, 27439, 68730, 69112 or 52908 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 14275, 54420, 8797, 27439, 68730, 69112 or 52908 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 14275, 54420, 8797, 27439, 68730, 69112 or 52908 gene has been introduced or disrupted. The invention still further provides isolated 14275, 54420, 8797, 27439, 68730, 69112 or 52908 proteins, fusion proteins, antigenic peptides and anti-14275, 54420, 8797, 27439, 68730, 69112 or 52908 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 03-12-2009 |
| 20090226449 | Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921, and 33751 molecules and uses therefor - The invention provides isolated nucleic acids molecules, designated 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 gene has been introduced or disrupted. The invention still further provides isolated 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 proteins, fusion proteins, antigenic peptides and anti-18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 or 33751 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 09-10-2009 |
| 20100150901 | 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor - The invention provides isolated nucleic acids molecules, designated 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 and 8843 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 and 8843 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 or 8843 gene has been introduced or disrupted. The invention still further provides isolated 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 or 8843 proteins, fusion proteins, antigenic peptides and anti-26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 or 8843 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 06-17-2010 |
| 20110150860 | NOVEL 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 AND 49933 MOLECULES AND USES THEREFOR - The invention provides isolated nucleic acids molecules, designated 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 gene has been introduced or disrupted. The invention still further provides isolated 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 proteins, fusion proteins, antigenic peptides and anti-25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 06-23-2011 |
| 20110171205 | NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR - The invention provides isolated nucleic acids molecules, designated 15571, 2465, 14266, 2882, 52871, 8203 or 16852 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 15571, 2465, 14266, 2882, 52871, 8203 or 16852 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 15571, 2465, 14266, 2882, 52871, 8203 or 16852 gene has been introduced or disrupted. The invention still further provides isolated 15571, 2465, 14266, 2882, 52871, 8203 or 16852 proteins, fusion proteins, antigenic peptides and anti-15571, 2465, 14266, 2882, 52871, 8203 or 16852 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 07-14-2011 |
Rory A. J. Curtis, Southborough, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110033892 | NOVEL MEMBERS OF THE CAPSAICIN/VANILLOID RECEPTOR FAMILY OF PROTEINS AND USES THEREOF - The invention provides isolated nucleic acids molecules, designated hVR-1, hVR-2, and rVR-2 nucleic acid molecules, which encode novel members of the Capsaicin/Vanilloid receptor family. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing hVR-1, hVR-2, and rVR-2 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an hVR-1, hVR-2, and rVR-2 gene has been introduced or disrupted. The invention still further provides isolated hVR-1, hVR-2, and rVR-2 proteins, fusion proteins, antigenic peptides and anti-hVR-1, anti-hVR-2, and anti-rVR-2 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. | 02-10-2011 |
| 20110300560 | NOVEL MEMBERS OF THE CAPSAICIN/VANILLOID RECEPTOR FAMILY OF PROTEINS AND USES THEREOF - The invention provides isolated nucleic acids molecules, designated hVR-1, hVR-2, and rVR-2 nucleic acid molecules, which encode novel members of the Capsaicin/Vanilloid receptor family. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing hVR-1, hVR-2, and rVR-2 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an hVR-1, hVR-2, and rVR-2 gene has been introduced or disrupted. The invention still further provides isolated hVR-1, hVR-2, and rVR-2 proteins, fusion proteins, antigenic peptides and anti-hVR-1, anti-hVR-2, and anti-rVR-2 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. | 12-08-2011 |
Rory A. J. Curtis, Framingham, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090324608 | Novel human protein kinase, phosphatase, and protease family members and uses thereof - The invention provides isolated nucleic acids molecules, designated 53070, 15985, 26583, 21953, m32404, 14089, and 23436 nucleic acid molecules, which encode novel human protein kinase family members, serine/threonine protein kinase family members, serine/threonine phosphatase family members, prolyl oligopeptidase family members, trypsin family members, trypsin serine protease family members, and ubiquitin protease family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 53070, 15985, 26583, 21953, m32404, 14089, or 23436 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 53070, 15985, 26583, 21953, m32404, 14089, or 23436 gene has been introduced or disrupted. The invention still further provides isolated 53070, 15985, 26583, 21953, m32404, 14089, or 23436 proteins, fusion proteins, antigenic peptides and anti-53070, 15985, 26583, 21953, m32404, 14089, or 23436 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. | 12-31-2009 |
Rory A. J. Curtis, Ashland, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20080241133 | Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor - The invention provides isolated nucleic acids molecules, designated 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 gene has been introduced or disrupted. The invention still further provides isolated 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 proteins, fusion proteins, antigenic peptides and anti-25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 10-02-2008 |
Stephen Curtis, Natick, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120084664 | METHOD AND SYSTEM FOR BINDING GRAPHICAL INTERFACES TO TEXTUAL CODE - In an embodiment, a method of binding a human machine interface to an expression of existing computer code may include analyzing the existing computer code to identify one or more bindable expressions in the existing computer code, and receiving a command to bind a human machine interface with one or more of the identified bindable expressions. The method may further include binding, using a processor, one or more of the bindable expressions with the human machine interface in response to the command. The binding may enable the human machine interface to communicate information within the existing computer code in place of the one or more bound expressions. The bound machine interface may communicate information within the computer code while the computer code is executing. | 04-05-2012 |